Andreas Freitag

Andreas Freitag has extensive experience in the pharmaceutical and consulting industries, currently serving as Director ESG at CureVac since July 2021, where responsibilities include implementing ESG practices and ensuring regulatory compliance. Previously held positions include Director Corporate Program Management at CureVac, Head of R&D Central Services at AbbVie, and various roles at AbbVie, AbbVie Logistics B.V., and Abbott, focusing on project management, supply chain planning, and organizational transformation. Education includes a Diploma in Economics from the University of Hohenheim and a Diploma in Finance, Tax, and Law from the University of Applied Science Ludwigsburg.